| Year |
Citation |
Score |
| 2022 |
Zhou K, Cheong JE, Tarakkad Krishnaji S, Ghalali A, Fu H, Sui L, Alix-Panabieres C, Cayrefourcq L, Bielenberg D, Sun L, Zetter BR. Inhibition of Wnt signaling in colon cancer cells via an oral drug that facilitates TNIK degradation. Molecular Cancer Therapeutics. PMID 36302395 DOI: 10.1158/1535-7163.MCT-21-0801 |
0.306 |
|
| 2020 |
Chung I, Zhou K, Barrows C, Banyard J, Wilson A, Rummel N, Mizokami A, Basu S, Sengupta P, Shaikh B, Sengupta S, Bielenberg DR, Zetter BR. Unbiased Phenotype-Based Screen Identifies Therapeutic Agents Selective for Metastatic Prostate Cancer. Frontiers in Oncology. 10: 594141. PMID 33738243 DOI: 10.3389/fonc.2020.594141 |
0.353 |
|
| 2020 |
Zhang J, Yin Y, Wang J, Zhang J, Liu H, Feng W, Yang W, Zetter B, Xu Y. Prohibitin regulates mTOR pathway via interaction with FKBP8. Frontiers of Medicine. PMID 33259040 DOI: 10.1007/s11684-020-0805-6 |
0.389 |
|
| 2020 |
Ghalali A, Stopsack KH, Rice JM, Wang L, Wu S, Wu CL, Zetter B, Rogers MS. Abstract 1822: RNA eding of AZIN1 increases cellular aggressiveness in prostate cancer Cancer Research. 80: 1822-1822. DOI: 10.1158/1538-7445.Am2020-1822 |
0.449 |
|
| 2019 |
Ghalali A, Rice JM, Wang L, Wu CL, Rogers MS, Zetter B. Abstract 4888: Nuclear localization of antizyme inhibitor may be a marker for aggressiveness of prostate cancer Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-4888 |
0.369 |
|
| 2019 |
Zhou K, Cheong JE, Zaffagni M, Xu Y, Sun L, Zetter B. Abstract 14: A new orally available drug for the treatment of metastatic cancers Cancer Research. 79: 14-14. DOI: 10.1158/1538-7445.Sabcs18-14 |
0.479 |
|
| 2018 |
Islam MA, Xu Y, Tao W, Ubellacker JM, Lim M, Aum D, Lee GY, Zhou K, Zope H, Yu M, Cao W, Oswald JT, Dinarvand M, Mahmoudi M, Langer R, ... ... Zetter BR, et al. Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA. Nature Biomedical Engineering. 2: 850-864. PMID 31015614 DOI: 10.1038/S41551-018-0284-0 |
0.321 |
|
| 2018 |
Sun L, Cheong JE, Zaffagni M, Zhou K, Zetter B. Abstract 1670: Discovery of novel water-soluble derivatives of mebendazole as selective CLK1/4 kinase inhibitors and their anticancer cancer activity Cancer Research. 78: 1670-1670. DOI: 10.1158/1538-7445.Am2018-1670 |
0.418 |
|
| 2017 |
Cheong JE, Zaffagni M, Chung I, Xu Y, Wang Y, Jernigan FE, Zetter BR, Sun L. Synthesis and anticancer activity of novel water soluble benzimidazole carbamates. European Journal of Medicinal Chemistry. 144: 372-385. PMID 29288939 DOI: 10.1016/J.Ejmech.2017.11.037 |
0.324 |
|
| 2017 |
Islam MA, Xu Y, Zope H, Cao W, Mahmoudi M, Langer R, Kantoff PW, Shi J, Zetter BR, Farokhzad OC. Restoration of tumor suppression in vivo by systemic delivery of chemically-modified PTEN mRNA nanoparticles. Journal of Clinical Oncology. 35: 11582-11582. DOI: 10.1200/Jco.2017.35.15_Suppl.11582 |
0.353 |
|
| 2015 |
Connor Y, Tekleab S, Nandakumar S, Walls C, Tekleab Y, Husain A, Gadish O, Sabbisetti V, Kaushik S, Sehrawat S, Kulkarni A, Dvorak H, Zetter B, R Edelman E, Sengupta S. Physical nanoscale conduit-mediated communication between tumour cells and the endothelium modulates endothelial phenotype. Nature Communications. 6: 8671. PMID 26669454 DOI: 10.1038/Ncomms9671 |
0.394 |
|
| 2015 |
Wang L, Xu Y, Wu S, Fergus M, Wu C, Zetter B. Abstract 4340: Nuclear expression of antizyme inhibitor is associated with poor prostate cancer prognosis Cancer Research. 75: 4340-4340. DOI: 10.1158/1538-7445.Am2015-4340 |
0.4 |
|
| 2014 |
Zetter B, Lake F. Advancing treatment of metastatic cancers: from research to communication--where do we need to go? Future Oncology (London, England). 10: 1535-40. PMID 25145423 DOI: 10.2217/Fon.14.100 |
0.308 |
|
| 2014 |
Connor YD, Tekleab S, Husain A, Walls C, Zetter B, Dvorak H, Sengupta S. Abstract 3600: NanoChannel-mediated communication between tumor cells and endothelium mediates metastatic parasitism Cancer Research. 74: 3600-3600. DOI: 10.1158/1538-7445.Am2014-3600 |
0.495 |
|
| 2013 |
Coughlin MF, Bielenberg DR, Lenormand G, Marinkovic M, Waghorne CG, Zetter BR, Fredberg JJ. Cytoskeletal stiffness, friction, and fluidity of cancer cell lines with different metastatic potential. Clinical & Experimental Metastasis. 30: 237-50. PMID 22961212 DOI: 10.1007/S10585-012-9531-Z |
0.352 |
|
| 2012 |
Olsen RR, Chung I, Zetter BR. Knockdown of antizyme inhibitor decreases prostate tumor growth in vivo. Amino Acids. 42: 549-58. PMID 21909979 DOI: 10.1007/S00726-011-1032-X |
0.716 |
|
| 2011 |
Cao Y, Arbiser J, D'Amato RJ, D'Amore PA, Ingber DE, Kerbel R, Klagsbrun M, Lim S, Moses MA, Zetter B, Dvorak H, Langer R. Forty-year journey of angiogenesis translational research. Science Translational Medicine. 3: 114rv3. PMID 22190240 DOI: 10.1126/Scitranslmed.3003149 |
0.349 |
|
| 2011 |
Spivey KA, Chung I, Banyard J, Adini I, Feldman HA, Zetter BR. A role for collagen XXIII in cancer cell adhesion, anchorage-independence and metastasis. Oncogene. 31: 2362-72. PMID 21963851 DOI: 10.1038/Onc.2011.406 |
0.352 |
|
| 2011 |
Olsen RR, Zetter BR. Evidence of a role for antizyme and antizyme inhibitor as regulators of human cancer. Molecular Cancer Research : McR. 9: 1285-93. PMID 21849468 DOI: 10.1158/1541-7786.Mcr-11-0178 |
0.713 |
|
| 2011 |
Holleman A, Chung I, Olsen RR, Kwak B, Mizokami A, Saijo N, Parissenti A, Duan Z, Voest EE, Zetter BR. miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo. Oncogene. 30: 4386-98. PMID 21552288 DOI: 10.1038/Onc.2011.148 |
0.68 |
|
| 2010 |
Spivey KA, Banyard J, Solis LM, Wistuba II, Barletta JA, Gandhi L, Feldman HA, Rodig SJ, Chirieac LR, Zetter BR. Collagen XXIII: a potential biomarker for the detection of primary and recurrent non-small cell lung cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 1362-72. PMID 20447926 DOI: 10.1158/1055-9965.Epi-09-1095 |
0.306 |
|
| 2010 |
Patel N, Chatterjee SK, Vrbanac V, Chung I, Mu CJ, Olsen RR, Waghorne C, Zetter BR. Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 107: 2503-8. PMID 20133800 DOI: 10.1073/Pnas.0910649107 |
0.694 |
|
| 2010 |
Chung I, Barrows C, Wilson A, Rummel N, Badaruddin S, Mizokami A, Banyard J, Zetter B. Abstract 1551: Benzimidazole as novel therapeutic agent for metastatic prostate cancer Cancer Research. 70: 1551-1551. DOI: 10.1158/1538-7445.Am10-1551 |
0.474 |
|
| 2009 |
Banyard J, Barrows C, Zetter BR. Differential regulation of human thymosin beta 15 isoforms by transforming growth factor beta 1. Genes, Chromosomes & Cancer. 48: 502-9. PMID 19296525 DOI: 10.1002/gcc.20659 |
0.354 |
|
| 2007 |
Mangold U, Hayakawa H, Coughlin M, Münger K, Zetter BR. Antizyme, a mediator of ubiquitin-independent proteasomal degradation and its inhibitor localize to centrosomes and modulate centriole amplification. Oncogene. 27: 604-13. PMID 17667942 DOI: 10.1038/Sj.Onc.1210685 |
0.309 |
|
| 2006 |
Kim SW, Mangold U, Waghorne C, Mobascher A, Shantz L, Banyard J, Zetter BR. Regulation of cell proliferation by the antizyme inhibitor: evidence for an antizyme-independent mechanism. Journal of Cell Science. 119: 2583-91. PMID 16735445 DOI: 10.1242/Jcs.02966 |
0.586 |
|
| 2004 |
Everley PA, Krijgsveld J, Zetter BR, Gygi SP. Quantitative cancer proteomics: stable isotope labeling with amino acids in cell culture (SILAC) as a tool for prostate cancer research. Molecular & Cellular Proteomics : McP. 3: 729-35. PMID 15102926 DOI: 10.1074/Mcp.M400021-Mcp200 |
0.326 |
|
| 2003 |
Kisker O, Onizuka S, Becker CM, Fannon M, Flynn E, D'Amato R, Zetter B, Folkman J, Ray R, Swamy N, Pirie-Shepherd S. Vitamin D binding protein-macrophage activating factor (DBP-maf) inhibits angiogenesis and tumor growth in mice. Neoplasia (New York, N.Y.). 5: 32-40. PMID 12659668 DOI: 10.1016/S1476-5586(03)80015-5 |
0.474 |
|
| 2002 |
Parsons JT, Zetter B, Mohla S. Shifting paradigms in tumor metastasis: Challenges and opportunities Cancer Biology and Therapy. 1: 582-585. PMID 12496493 DOI: 10.4161/Cbt.1.5.226 |
0.359 |
|
| 2002 |
Becker CM, Farnebo FA, Iordanescu I, Behonick DJ, Shih MC, Dunning P, Christofferson R, Mulligan RC, Taylor GA, Kuo CJ, Zetter BR. Gene therapy of prostate cancer with the soluble vascular endothelial growth factor receptor Flk1. Cancer Biology & Therapy. 1: 548-53. PMID 12496487 DOI: 10.4161/Cbt.1.5.176 |
0.328 |
|
| 2002 |
Iordanescu I, Becker C, Zetter B, Dunning P, Taylor GA. Tumor vascularity: evaluation in a murine model with contrast-enhanced color Doppler US effect of angiogenesis inhibitors. Radiology. 222: 460-7. PMID 11818614 DOI: 10.1148/Radiol.2222010660 |
0.408 |
|
| 2000 |
Eadie JS, Kim SW, Allen PG, Hutchinson LM, Kantor JD, Zetter BR. C-terminal variations in β-thymosin family members specify functional differences in actin-binding properties Journal of Cellular Biochemistry. 77: 277-287. PMID 10723093 DOI: 10.1002/(SICI)1097-4644(20000501)77:2<277::AID-JCB10>3.0.CO;2-Q |
0.449 |
|
| 1999 |
Arbiser JL, Karalis K, Viswanathan A, Koike C, Anand-Apte B, Flynn E, Zetter B, Majzoub JA. Corticotropin-releasing hormone stimulates angiogenesis and epithelial tumor growth in the skin. The Journal of Investigative Dermatology. 113: 838-42. PMID 10571742 DOI: 10.1046/J.1523-1747.1999.00760.X |
0.314 |
|
| 1999 |
Banyard J, Zetter BR. The role of cell motility in prostate cancer. Cancer Metastasis Reviews. 17: 449-58. PMID 10453290 DOI: 10.1023/A:1006150007710 |
0.378 |
|
| 1998 |
Claesson-Welsh L, Welsh M, Ito N, Anand-Apte B, Soker S, Zetter B, O'Reilly M, Folkman J. Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD. Proceedings of the National Academy of Sciences of the United States of America. 95: 5579-83. PMID 9576925 DOI: 10.1073/Pnas.95.10.5579 |
0.372 |
|
| 1998 |
Bao L, Loda M, Zetter BR. Thymosin beta15 expression in tumor cell lines with varying metastatic potential. Clinical & Experimental Metastasis. 16: 227-33. PMID 9568640 DOI: 10.1023/A:1006540824969 |
0.316 |
|
| 1998 |
Zetter BR. Angiogenesis and tumor metastasis. Annual Review of Medicine. 49: 407-24. PMID 9509272 DOI: 10.1146/ANNUREV.MED.49.1.407 |
0.32 |
|
| 1997 |
Anand-Apte B, Zetter B. Signaling mechanisms in growth factor-stimulated cell motility. Stem Cells (Dayton, Ohio). 15: 259-67. PMID 9253109 DOI: 10.1002/Stem.150259 |
0.353 |
|
| 1997 |
Anand-Apte B, Bao L, Smith R, Iwata K, Olsen BR, Zetter B, Apte SS. A review of tissue inhibitor of metalloproteinases-3 (TIMP-3) and experimental analysis of its effect on primary tumor growth. Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire. 74: 853-62. PMID 9164653 DOI: 10.1139/O96-090 |
0.449 |
|
| 1997 |
Bao L, Loda M, Janmey PA, Stewart R, Anand-Apte B, Zetter BR. Thymosin beta 15: a novel regulator of tumor cell motility upregulated in metastatic prostate cancer. Nature Medicine. 2: 1322-8. PMID 8946830 DOI: 10.1038/Nm1296-1322 |
0.323 |
|
| 1991 |
Zetter BR. Cell motility in angiogenesis and tumor metastasis. Cancer Investigation. 8: 669-71. PMID 1705474 DOI: 10.3109/07357909009018942 |
0.342 |
|
| 1990 |
Hemler ME, Elices MJ, Chan BM, Zetter B, Matsuura N, Takada Y. Multiple ligand binding functions for VLA-2 (alpha 2 beta 1) and VLA-3 (alpha 3 beta 1) in the integrin family. Cell Differentiation and Development : the Official Journal of the International Society of Developmental Biologists. 32: 229-38. PMID 1965952 DOI: 10.1016/0922-3371(90)90035-U |
0.333 |
|
| 1989 |
Yusa T, Blood CH, Zetter BR. Tumor cell interactions with elastin: implications for pulmonary metastasis. The American Review of Respiratory Disease. 140: 1458-62. PMID 2817613 DOI: 10.1164/AJRCCM/140.5.1458 |
0.31 |
|
| 1987 |
Sitaras NM, Sariban E, Pantazis P, Zetter B, Antoniades HN. Human iliac artery endothelial cells express both genes encoding the chains of platelet-derived growth factor (PDGF) and synthesize PDGF-like mitogen. Journal of Cellular Physiology. 132: 376-80. PMID 3040782 DOI: 10.1002/Jcp.1041320228 |
0.341 |
|
| 1984 |
Netland PA, Zetter BR. Organ-specific adhesion of metastatic tumor cells in vitro. Science (New York, N.Y.). 224: 1113-5. PMID 6372098 DOI: 10.1126/Science.6372098 |
0.417 |
|
| 1981 |
Tapper D, Scheiner C, Frissora H, Zetter B. The stimulation of capillary endothelial cell migration by aqueous humor. The Journal of Surgical Research. 30: 262-8. PMID 7230775 DOI: 10.1016/0022-4804(81)90158-X |
0.367 |
|
| 1978 |
Gospodarowicz D, Brown KD, Birdwell CR, Zetter BR. Control of proliferation of human vascular endothelial cells. Characterization of the response of human umbilical vein endothelial cells to fibroblast growth factor, epidermal growth factor, and thrombin Journal of Cell Biology. 77: 774-778. PMID 308066 DOI: 10.1083/Jcb.77.3.774 |
0.346 |
|
| Show low-probability matches. |